Anticardiolipin and antibeta2glycoproteinI antibodies in patients with hepatitis B and C infections

Iranian Journal of Immunology

Volumn 4, Issue 3, 2007, Pages 161-166

  Habibagahi, Zahra ^a,b   Nazarinia, Mohammad Ali ^a   Aflaki, Elham ^a   Rajaee, Akbar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticardiolipin antibody; Antiphospholipid syndrome; Hepatitis B; Hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PROTHROMBIN TIME; THROMBOCYTE COUNT; BLOOD; IMMUNOLOGY; IRAN; VIROLOGY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; IRAN; MALE;

EID: 35349018410     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bick RL. Antiphospholipid thrombosis syndromes. Hematol Oncol Clin North Am. 2003; 17:115-47.
2. Roubey RA. Update on antiphospholipid antibodies. Curr Opin Rheumatol. 2000; 12:374-8.
3. Matsuura E, Igarashi M, Igarashi Y, Katahira T, Nagae H, Ichikawa K et al. Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies. Lupus 1994;1: S13-7.
4. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177-8.
5. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.. J Immunnol 1992; 148: 3885-91.
6. McNally T, Purdy G, Mackie IJ, Machin SJ, Isenberg DA. The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Hematol 1995; 91:471-73.
7. Roubey RA, Pratt CW, Buyon JP, Winfield JB. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J Clin Invest 1992; 90: 1100-104
8. Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Current Rheumatol Rep 2001; 3:277-85.
9. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmune 1999; 13: 347-55.
10. Vlachoyiannopoulos PG, Petrovas C, Tektonidou M, Krilis S, Moutsopoulos HM.Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis. J Clin Immunol 1998; 18:380-91.
11. Uthman I, Tabbarah Z, Gharavi AE. Hughes syndrome associated with cytomegalovirus infection. Lupus 1999; 8:775-7.
12. Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. . Hepatology. 1996; 23:199-204.
13. Jaeger U, Kapiotis S, Pabinger I, Puchhammer E, Kyrle PA, Lechner K. Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection. Ann. Hematol. 1993; 67:95-9.
14. Loizou S, Cazabon JK, Walport MJ, Tait D, So AK. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus . Arthritis Rheum. 1997; 40:103-8.
15. Loizou S, Singh S, Wypkema E, Asherson RA. Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum 2003; 62:1106-111
16. Zachou K, Liaskos C, Christodoulou DK, Kardasi M, Papadamou G, Gatselis N et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome.Eur. J. Clin. Invest. 2003; 33:161-8.
17. Gharavi AE, Pierangeli SS, Harris EN. New developments in viral peptides and APL induction.J. Autoimmun. 2000; 15:227-30.
18. Petrovas C, Vlachoyiannopoulos PG, Kordossis T. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimun 1999; 13:347-355.
19. Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E.Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann. Rheum. Dis. 2001; 60:500-4.
20. Koike T, Ichikawa K, Kasahara H, Atsumi T, Tsutsumi A, Matsuura E. Epitopes on beta2-GPI recognized by anticardiolipin antibodies Lupus. 1998; 7:S14-7.
21. Gharavi AE, Pierangeli SS, Harris EN. Origin of antiphosphiliupids. Rheum Dis Clin North Am 2001; 27:551-63.